Results 81 to 90 of about 19,660 (219)

A computational study on the mercaptopurine drug interaction with aluminum nitride nanostructures: analyzed by Marcus theory of electron-transfer

, 2023
We analyzed the mercaptopurine adsorption on AlN nanostructures consisting of zero-dimensional nanoclusters, one-dimensional nanotubes, and two-dimensional nanosheets using calculations based on density functional theory (DFT).
Ali Alsalamy (16499583), Khalid Mujasam Batoo (17317567), Mazin Hadi Kzar (17279869), Ahmed Hussien Alawadi (17279887), F. Al-dolaimy (17317564), Noor Hanoon Haroon (17317573), Sajjad Hussain (41458), Zahraa Sabah Ghnim (17317570), Hamed Soleymanabadi (17317576)   +8 more
core   +1 more source

Comparison of pharmacogenomic guidance in Australian prescribing resources and international pharmacogenomic guidelines

Internal Medicine Journal, EarlyView.
Abstract Background Pharmacogenomic‐guided medication management optimises drug therapy to enhance patient outcomes. Despite clinical utility, implementation in Australia remains limited, partly due to the lack of clear and consistent guidance. Aim This study evaluated the presence and consistency of pharmacogenomic testing indication categories and ...
Ruby Soueid, Jackson L. A. Thomas, Luke B. Hesson, Stephen Hughes, Sophie L. Stocker   +4 more
wiley   +1 more source

Partnered Pharmacist Medication Charting for Children and Young People: A Retrospective Cohort Study

Journal of Paediatrics and Child Health, EarlyView.
ABSTRACT Aim Partnered pharmacist medication charting (PPMC) reduces medication errors in Australian adult hospitals. This study evaluated the impact of PPMC on paediatric emergency department (ED) presentations compared to early best possible medication history (BPMH) and usual care.
Georgia Lloyd, Brooke McCarthy, Polly Ng, Christopher Johansson, Felicity Wright   +4 more
wiley   +1 more source

MERCAPTOPURINE AND SILYLATED MERCAPTOPURINE IN THE TREATMENT OF THE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

, 1990
VOHL ML, WESTARP ME, WEKERLE H, GERLACH M, Jutzi P, PRZUNTEK H. MERCAPTOPURINE AND SILYLATED MERCAPTOPURINE IN THE TREATMENT OF THE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS. ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH.
VOHL, ML, Jutzi, Peter, PRZUNTEK, H, WEKERLE, H, WESTARP, ME, GERLACH, M   +5 more
core  

Hair loss in pediatric inflammatory bowel disease: Clinical recognition and implications for care

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Angela Anaeme, Liza Siegel, Meryl Perlman   +2 more
wiley   +1 more source

Salivary Methotrexate as a Predictor of Oral Mucositis in Hematological Cancer Patients: A Phase II Randomized, Double‐Blind Clinical Trial

Oral Diseases, EarlyView.
ABSTRACT Objective To evaluate the efficacy of prophylactic photobiomodulation therapy (PBMT) in preventing oral mucositis (OM) and to assess serum and salivary methotrexate (MTX) levels as predictors of OM in adults receiving high‐dose methotrexate (HD‐MTX).
Letícia Rodrigues‐Oliveira, Carolina Guimarães Bonfim, Ana Leticia Mores, Natalia Rangel Palmier, Henrique Ballassini Abdalla, Juliana Trindade Clemente‐Napimoga, Iara Gonçalves Aquino, Maria Cecilia Querido de Oliveira, Maria Cláudia Cuzzullin, Aljomar Jose Vechiato Filho, Cesar Rivera, Tatiana Natasha Toporcov, Juliana Pereira, Luiz Alcino Gueiros, Rossana Veronica Mendoza López, Manoela Domingues Martins, Marcelo Lazzaron Lamers, Karina Morais‐Faria, Pablo Agustin Vargas, Alan Roger Santos‐Silva, Thais Bianca Brandão, Ana Carolina Prado‐Ribeiro   +21 more
wiley   +1 more source

TNFSF14/LIGHT responses in intestinal and oesophageal fibroblasts are differentially modulated by hydroxylase inhibitors

The Journal of Physiology, EarlyView.
Abstract figure legend LIGHT is a mutual mediator of intestinal and oesophageal fibroblast inflammation with common as well as tissue‐specific effects. Hydroxylase inhibitors can selectively suppress inflammatory factors in both cell types, albeit targeting different signalling pathways.
Cian M. Ohlendieck, Carlos Matellan, Cristina Bauset, Bella Raphael, Mary Nwaezeigwe, Emer Flynn, Kevin Okamoto, Desmond Winter, Colm Collins, Katie Doogan, Seán T. Martin, Glen Doherty, Seema S. Aceves, Mario C. Manresa   +13 more
wiley   +1 more source

Frequency of Use and Standards of Care for the Use of Azathioprine and 6-Mercaptopurine in Treatment of Inflammatory Bowel Disease: A Systematic Review of the Literature and a Survey of Canadian Gastroenterologists

Canadian Journal of Gastroenterology, 2001
OBJECTIVE: To identify the frequency of use and appropriate monitoring guidelines for the adverse effects of azathioprine and 6-mercaptopurine (6-MP) in the therapy of patients with inflammatory bowel disease (IBD).
Thomas M Wallace, Sander JO Veldhuyzen van Zanten   +1 more
doaj   +1 more source

Mercaptopurine-induced Sweet\u2019s syndrome

Sweet\u2019s syndrome is an acute febrile neutrophilic dermatosis. Drug-induced Sweet\u2019s syndrome typically occurs soon after drug administration, with rapid resolution of symptoms with cessation of the offending agent.
Patrick, Desmond, Subhaharan, Deloshaan, Dettrick, Andrew, Commins, Natalie   +3 more
core   +1 more source

Antiviral Potential of Azathioprine and Its Derivative 6- Mercaptopurine: A Narrative Literature Review

Pharmaceuticals
The use of azathioprine (AZA) in human medicine dates back to research conducted in 1975 that led to the development of several drugs, including 6-mercaptopurine.
Carolina Rios-Usuga, Marlen Martinez-Gutierrez, Julian Ruiz-Saenz   +2 more
doaj   +1 more source